Filing Details
- Accession Number:
- 0001209191-20-049511
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-09-03 17:54:43
- Reporting Period:
- 2020-09-01
- Accepted Time:
- 2020-09-03 17:54:43
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1731348 | Tilray Inc. | TLRY | Medicinal Chemicals & Botanical Products (2833) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1746224 | Maryscott Greenwood | 1100 Maughan Road Nanaimo A1 V9X IJ2 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Class 2 Common Stock | Acquisiton | 2020-09-01 | 2,187 | $0.00 | 21,391 | No | 4 | M | Direct | |
Class 2 Common Stock | Disposition | 2020-09-01 | 5,000 | $6.44 | 16,391 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Class 2 Common Stock | Restricted Stock Units | Disposition | 2020-09-01 | 2,187 | $0.00 | 2,187 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
15,313 | 2020-09-01 | No | 4 | A | Direct |
Footnotes
- Each restricted stock unit ("RSU") converted into one share of Class 2 Common Stock.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.36 to $6.58, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote 3 to this Form 4.
- Each RSU represents a contingent right to receive one share of the Issuer's Class 2 Common Stock.
- The RSUs shall vest at the rate of 25% of the RSUs on the twelve (12) month anniversary of June 1, 2018 (the "Vesting Date"), and the remaining RSUs will vest quarterly thereafter at the rate of 6.25% of the total number of RSUs on each quarterly anniversary of the Vesting Date thereafter for so long as the Reporting Person remains in Continuous Service (as defined in the Issuer's 2018 Equity Incentive Plan), such that the total number of RSUs shall be fully vested on the four-year anniversary of the Vesting Date.